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Clinical practice guidelines (CPGs) provide to clinicians
specific recommendations for practice, but there are
concerns about their quality due to an increasing number in
the last years. We aimed to systematically assess the
methodological quality of guidelines for the management of
low back pain (LBP).
Methods
Comprehensive searches in Pubmed and Embase, TRIP
database, National/International databases and guidelines
websites were undertaken up to 23 January 2019 to identify
all CPGs assessing recommendations on rehabilitation,
pharmacological or surgical therapeutic interventions for
LBP management. In order to guarantee the most update
evidence coming from CPGs, only those published since
2016 have been included. Two authors independently
screened and selected the records according to the
eligibility criteria. The primary outcome was the evaluation
of quality of guidelines reporting. Four reviewers
independently evaluated eligible guidelines by using the
Appraisal of Guidelines for Research and Evaluation II
(AGREE II) assessment tool. According to the AGREE II User’s
Manual, the six domains of the instrument are independent
and calculated according to AGREE’s formula. Domain scores
were categorized as good (≥ 80%), acceptable (60–79%), low
(40–59%), or very low (< 40%). Finally, we defined high
quality when all the domains scored > 60%, average quality
when 3, 4 or 5 domains scored > 60%, and low quality when
≤ 2 domains scored > 60%. The secondary outcome was the
inter-rater reliability between raters calculated using the
intraclass correlation coefficient.
The systematic search generated 1195 database citations
and 30 grey literature links. A total of 56 guidelines and
related documents underwent full-text screening, of which
11 met the inclusion criteria for AGREE II assessment.
Intraobserver agreement was good (overall intraclass
correlation coefficient of 0.882, 95% confidence interval
0.857–0.904). Overall, the highest rating AGREE II domains
were Editorial Independence’ (mean 75,4%, range 33,3 –
95,8%), ‘Scope and Purpose’ (mean 69,8%, range 20,8 –
98,6%) and ‘Clarity and Presentation’ (mean 67,9%, range
19,4 – 100%). The lowest rating domains were ‘Rigour of
Development’ (mean 60,8%, range 1,96 – 90,1%),
‘Stakeholder Involvement’ (mean 56,4%, range 0 – 95,8%)
and ‘Applicability’ (mean 39,2%, range 0 – 86,5%). The
National Institute for Health and Care Excellence guideline
performed best with respect to AGREE II criteria; only two
other CPGs warranted high scores on all domains. All other
guidelines received scores of under 60% on one or more
domains (Table 1).
In the overall evaluation, three guidelines were considered
‘high quality’, four ‘medium quality’, and four ‘low quality’.
The results of this review can help researchers and Italian
policymakers to select and adopt the highest quality GPCs
for LBP management in the GPCs national system (Sistema
Nazionale Linee Guida - SNLG).
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Table 1. Quality assessment of all included CPGs. 
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